RS Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-370,574
Closed -$27.5M 355
2015
Q3
$27.5M Buy
370,574
+41,530
+13% +$2.97M 0.25% 149
2015
Q2
$21.1M Sell
329,044
-13,640
-4% -$944K 0.18% 186
2015
Q1
$26.5M Sell
342,684
-60,516
-15% -$4.71M 0.24% 155
2014
Q4
$29.9M Buy
403,200
+18,160
+5% +$1.27M 0.27% 137
2014
Q3
$22.7M Buy
385,040
+49,020
+15% +$3.1M 0.21% 159
2014
Q2
$22.4M Buy
+336,020
New +$21.4M 0.19% 165

Other funds holding IDXX

RS Investment Management's IDXX Position: Q4 2015 in Review

RS Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2015, closing a stake of 370,574 shares — an estimated $27.5M sold.

RS Investment Management first reported a position in IDXX in Q2 2014 and held it in 6 quarters. The position peaked at $29.9M in Q4 2014. 350 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

  • RS Investment Management reported no remaining Idexx Laboratories position as of Q4 2015 after selling out during the quarter.
  • RS Investment Management sold 370,574 Idexx Laboratories shares in Q4 2015, an estimated $27.5M.
  • RS Investment Management first reported a position in Idexx Laboratories in Q2 2014 and held it in 6 quarters.
  • RS Investment Management's Idexx Laboratories position peaked at $29.9M in Q4 2014.
  • 350 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on RS Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.